Trial intelligence / Profile preview

CROWN CORONATION COVID-19 prevention trial

ISRCTN99916292Phase 3Completed

Sponsor
University College London
Start
Oct 2020
Modality
Vaccines & Immunotherapeutics
01

Overview

Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing MMR vaccine with Placebo (2 arms). Primary endpoint: Symptomatic COVID-19 by day 60. Started Oct 2020; status: completed.

02

Drugs

measles, mumps, and rubella vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on ISRCTN99916292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN99916292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call